TIDMVSN

RNS Number : 5340L

Verseon Corporation

27 December 2018

Verseon Corporation ("Verseon" or the "Company")

Additional Listing and Total Voting Rights

Fremont, Calif.-Verseon, a technology-based pharmaceutical company, announces that application has been made for 39,250 new shares of common stock ("Common Shares") of par value US $0.001 each to be admitted to trading on AIM pursuant to regularly scheduled vesting of restricted stock units (the "Issuance").

The 39,250 new Common Shares issued pursuant to the Issuance will rank pari passu with the Company's existing Common Shares and admission to trading on AIM is expected to take place on December 28, 2018 ("Admission").

Total Voting Rights

Following Admission, the issued share capital of the Company will consist of 151,683,649 Common Shares and the Company will hold 42,917 shares in treasury. Therefore, the total number of Common Shares in the Company with voting rights will be 151,640,732. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

-Ends-

For further information please contact:

 
Verseon Corporation                                  www.verseon.com 
Sebastian Wykeham                                  +1 (510) 225 9000 
 
Arden Partners (NOMAD and Joint Broker) 
Ruari McGirr / Ciaran Walsh / 
 Maria Gomez De Olea                            +44 (0) 20 7614 5900 
 
Cantor Fitzgerald Europe (Joint Broker) 
Marc Milmo / Phil Davies / Callum Butterfield   +44 (0) 20 7894 7000

For financial and business media enquiries, please contact

 
Buchanan Communications Ltd (PR Advisors) 
Henry Harrison-Topham / Jamie Hooper   +44 (0) 20 7466 5000

For trade and pharma media enquiries, please contact

 
Vane Percy & Roberts 
Simon Vane Percy   +44 (0) 1737 821 890

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

MSCUBONRWOAUURA

(END) Dow Jones Newswires

December 27, 2018 02:01 ET (07:01 GMT)

Verseon (LSE:VSN)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Verseon Charts.
Verseon (LSE:VSN)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Verseon Charts.